Website sponsored 2014
About BRACAnalysis®BRACAnalysis®
Testing assesses a woman’s risk of developing hereditary breast or ovarian cancer based on the detection of mutations in the BRCA1 or BRCA2 genes.
BRCA mutations are responsible for the majority of hereditary breast cancers. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87% for breast cancer and up to 44% for ovarian cancer by age 70.
Mutation carriers previously diagnosed with cancer also have a significantly increased risk of developing a second primary cancer. Genetic testing, specifically BRACAnalysis, identifies patients who have these mutations. This test has become the standard of care in identification of individuals with hereditary breast and ovarian cancer.BRACAnalysis®
Results:
The results of BRACAnalysis testing help healthcare providers and their patients make more informed healthcare decisions. For example: A patient who knows they carry a BRCA mutation can start cancer screening at an earlier age. They can also choose options like risk-reducing medications and preventive surgery Healthcare providers can help patients move forward with the right action plan for their particular risks Patients already diagnosed with cancer may be able to prevent a second cancer Test results can help relatives learn and understand more about inherited risk and how it may affect them For more information about hereditary cancer testing, please visit links below:
This information is from Myriad.com
Hereditary Breast CancerApproximately 7% of breast cancer and 11 - 15% of ovarian cancer cases are caused by mutations in the BRCA1 or BRCA2 genes. When someone carries a mutation in either of these genes, they have a syndrome called Hereditary Breast and Ovarian Cancer (HBOC) syndrome.1,2,3 Myriad offers testing to determine whether a patient is a carrier of the BRCA1 or BRCA2 gene mutations. When assessing the risk of carrying these mutations a patient’s personal and family history is collected to investigate the risk for HBOC. Once a patient is identified as being at increased risk of HBOC, genetic test results provide the most accurate means of cancer risk assessment for a patient.
Hereditary Cancer Testing for Breast Cancer
The following questions can be asked to help determine whether
someone has a higher risk for breast cancer because of their own cancer
history and their family's history.
Knowing the potential risk can help the healthcare provider and
patient make better, more informed decisions about the patient’s health,
before the onset of cancer or before a second cancer has a chance to
develop. Testing should be considered for hereditary breast and ovarian
cancer if:
The Patient:
Has had breast cancer at age 50 or younger
Has had ovarian cancer at any age
Is male and has had breast cancer at any age
Is of Ashkenazi Jewish descent and has a personal or family history of breast, ovarian or pancreatic cancer*
The Patient’s Family:
Has had two breast cancers in the same person or on the same side of the family
Has had somebody diagnosed with triple negative breast cancer at any age
Has had pancreatic cancer and an HBOC-associated* cancer in the same person or on the same side of the family
Has three or more family members with breast cancer on the same side of the family
Has had a previously identified BRCA1 or BRCA2 mutation in the family
* HBOC-associated cancers are breast, ovarian and pancreatic.
**Assessment criteria based on medical society guidelines. For these individual medical society guidelines, go to www.myriadpro.com/guidelines
To help assess whether someone is a candidate for testing, they can take the Hereditary Cancer Quiz. This
quiz can help them get the information they need to discuss with their
risk of cancer with their healthcare provider and ask for further
evaluation. If someone matches any of the red flags above or takes the
quiz and finds red flags in their own history or their family history,
they may benefit from hereditary cancer testing.
About BRACAnalysis®
BRACAnalysis® testing assesses a woman’s risk of developing hereditary breast or ovarian cancer based on the detection of mutations in the BRCA1 or BRCA2 genes. BRCA mutations are responsible for the majority of hereditary breast cancers. People with a mutation in either the BRCA1 or BRCA2 gene
have risks of up to 87% for breast cancer and up to 44% for ovarian
cancer by age 70. Mutation carriers previously diagnosed with cancer
also have a significantly increased risk of developing a second primary
cancer. Genetic testing, specifically BRACAnalysis, identifies
patients who have these mutations. This test has become the standard of
care in identification of individuals with hereditary breast and ovarian
cancer.
BRACAnalysis® Results
The results of BRACAnalysis testing help healthcare providers and their patients make more informed healthcare decisions. For example:
A patient who knows they carry a BRCA mutation can start
cancer screening at an earlier age. They can also choose options like
risk-reducing medications and preventive surgery
Healthcare providers can help patients move forward with the right action plan for their particular risks
Patients already diagnosed with cancer may be able to prevent a second cancer
Test results can help relatives learn and understand more about inherited risk and how it may affect them
For more information about hereditary cancer testing see below.
* HBOC-associated cancers are breast, ovarian and pancreatic.**Assessment criteria based on medical society guidelines. For these individual medical society guidelines, go to www.myriadpro.com/guidelines
To help assess whether someone is a candidate for testing, they can take the Hereditary Cancer Quiz. This quiz can help them get the information they need to discuss with their risk of cancer with their healthcare provider and ask for further evaluation. If someone matches any of the red flags above or takes the quiz and finds red flags in their own history or their family history, they may benefit from hereditary cancer testing.
Please take the quiz
Hereditary Breast Cancer
The late- Mr. John W. Nick died from breast cancer June 11, 1991, at the age of 58.
I Tested Positive for the BRCA 2 Gene Early Detection Saved My Life.